Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Liver Transplantation | Research article

The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): a post-hoc between-sex analysis

Authors: Delia Colombo, Alessandro Zullo, Lucia Simoni, Emanuela Zagni, on behalf of the SURF Study Group

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Female sex has been reported as an independent predictor of severe post-liver transplantation (LT) chronic kidney disease. We performed a by sex post-hoc analysis of the SURF study, that investigated the prevalence of renal impairment following LT, aimed at exploring possible differences between sexes in the prevalence and course of post-LT renal damage.

Methods

All patients enrolled in the SURF study were considered evaluable for this sex-based analysis, whose primary objective was to evaluate by sex the proportion of patients with estimated Glomerular Filtration Rate (eGFR) < 60 ml/min/1.73m2 at inclusion and follow-up visit.

Results

Seven hundred thirty-eight patients were included in our analysis, 76% males. The proportion of patients with eGFR < 60 mL/min/1.73 m2 was significantly higher in females at initial study visit (33.3 vs 22.8%; p = 0.005), but also before, at time of transplantation (22.9 vs 14.7%; p = 0.0159), as analyzed retrospectively. At follow-up, such proportion increased more in males than in females (33.9 vs 26.0%, p = 0.04). Mean eGFR values decreased over the study in both sexes, with no significant differences. Statistically significant M/F differences in patient distribution by O’Riordan eGFR levels were observed at time of transplant and study initial visit (p = 0.0005 and 0.0299 respectively), but not at follow-up.

Conclusions

Though the limitation of being performed post-hoc, this analysis suggests potential sex differences in the prevalence of renal impairment before and after LT, encouraging further clinical research to explore such differences more in depth.
Literature
1.
go back to reference Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10(6):1420–7.PubMedPubMedCentralCrossRef Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10(6):1420–7.PubMedPubMedCentralCrossRef
3.
go back to reference Brown RS Jr, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver kidney transplantation. Transplantation. 1996;62:1788–93.PubMedCrossRef Brown RS Jr, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver kidney transplantation. Transplantation. 1996;62:1788–93.PubMedCrossRef
4.
go back to reference Knight SR, Oniscu GC, Devey L, Simpson KJ, Wigmore SJ, Harrison EM. Use of renal replacement therapy may influence graft outcomes following liver transplantation for acute liver failure: a propensity-score matched population-based retrospective cohort study. PLoS One. 2016;11(3):e0148782.PubMedPubMedCentralCrossRef Knight SR, Oniscu GC, Devey L, Simpson KJ, Wigmore SJ, Harrison EM. Use of renal replacement therapy may influence graft outcomes following liver transplantation for acute liver failure: a propensity-score matched population-based retrospective cohort study. PLoS One. 2016;11(3):e0148782.PubMedPubMedCentralCrossRef
5.
go back to reference Sanchez EQ, Gonwa TA, Levy MF, et al. Pre and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation (OLTX). Transplantation. 2004;78:1048–54.PubMedCrossRef Sanchez EQ, Gonwa TA, Levy MF, et al. Pre and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation (OLTX). Transplantation. 2004;78:1048–54.PubMedCrossRef
6.
go back to reference Gonwa TA, Klintmalm GB, Levy MF, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59:361–5.PubMedCrossRef Gonwa TA, Klintmalm GB, Levy MF, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59:361–5.PubMedCrossRef
7.
go back to reference Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing liver transplantation. Hepatology. 2002;35:1179–85.PubMedCrossRef Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing liver transplantation. Hepatology. 2002;35:1179–85.PubMedCrossRef
8.
go back to reference Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead US? Am J Transplant. 2006;6:2651–9.PubMedCrossRef Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead US? Am J Transplant. 2006;6:2651–9.PubMedCrossRef
9.
go back to reference Uhlig K, Eckardt KU. A decade after the KDOQI CKD guidelines: impact on CKD guidelines. Am J Kidney Dis. 2012;60(5):705–6.PubMedCrossRef Uhlig K, Eckardt KU. A decade after the KDOQI CKD guidelines: impact on CKD guidelines. Am J Kidney Dis. 2012;60(5):705–6.PubMedCrossRef
10.
go back to reference James MT, Hemmelgarn BR, Wiebe N, et al. Alberta kidney disease network. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet. 2010;376(9758):2096–103.PubMedCrossRef James MT, Hemmelgarn BR, Wiebe N, et al. Alberta kidney disease network. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet. 2010;376(9758):2096–103.PubMedCrossRef
11.
go back to reference Sanchez EQ, Melton LB, Chinnakotla S, et al. Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation. 2010;89(2):232–5.PubMedCrossRef Sanchez EQ, Melton LB, Chinnakotla S, et al. Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation. 2010;89(2):232–5.PubMedCrossRef
12.
go back to reference Brück K, Jager KJ, Dounousi E, et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant. 2015;30(Suppl 4):iv6–16.PubMedPubMedCentralCrossRef Brück K, Jager KJ, Dounousi E, et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant. 2015;30(Suppl 4):iv6–16.PubMedPubMedCentralCrossRef
13.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–70.PubMedCrossRef Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–70.PubMedCrossRef
14.
go back to reference Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19(2):122–34.PubMedCrossRef Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19(2):122–34.PubMedCrossRef
15.
go back to reference Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462–70.PubMedCrossRef Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462–70.PubMedCrossRef
16.
go back to reference Simoni L, Colombo D, Bellia G, Vassellatti D, Zagni E, Rizzoli S, Sgarbi S. A gender medicine post-hoc analysis: background and methods of the Metagem project. Value Health. 2014;17(7):A406.PubMedCrossRef Simoni L, Colombo D, Bellia G, Vassellatti D, Zagni E, Rizzoli S, Sgarbi S. A gender medicine post-hoc analysis: background and methods of the Metagem project. Value Health. 2014;17(7):A406.PubMedCrossRef
17.
go back to reference Gaspari F, Ferrari S, Stucchi N, et al. Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant. 2004;4(11):1826–35.PubMedCrossRef Gaspari F, Ferrari S, Stucchi N, et al. Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant. 2004;4(11):1826–35.PubMedCrossRef
18.
go back to reference Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004;10(2):301–9.PubMedCrossRef Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004;10(2):301–9.PubMedCrossRef
19.
go back to reference O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant. 2006;21(9):2630–6.PubMedCrossRef O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant. 2006;21(9):2630–6.PubMedCrossRef
20.
go back to reference Créput C, Blandin F, Deroure B, et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transpl. 2007;13(7):1004–10.PubMedCrossRef Créput C, Blandin F, Deroure B, et al. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation. Liver Transpl. 2007;13(7):1004–10.PubMedCrossRef
21.
go back to reference De Simone P, Carrai P, Precisi A, et al. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function. Transpl Int. 2009;22(3):279–86.PubMedCrossRef De Simone P, Carrai P, Precisi A, et al. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function. Transpl Int. 2009;22(3):279–86.PubMedCrossRef
22.
go back to reference De Simone P, Metselaar HJ, Fischer L, et al. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. Liver Transpl. 2009;15:1262–9.PubMedCrossRef De Simone P, Metselaar HJ, Fischer L, et al. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. Liver Transpl. 2009;15:1262–9.PubMedCrossRef
23.
go back to reference DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. Liver Transpl. 2008;14(5):651–9.PubMedCrossRef DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. Liver Transpl. 2008;14(5):651–9.PubMedCrossRef
24.
go back to reference Watson CJ, Gimson AE, Alexander GJ, et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl. 2007;13(12):1694–702.PubMedCrossRef Watson CJ, Gimson AE, Alexander GJ, et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl. 2007;13(12):1694–702.PubMedCrossRef
25.
go back to reference Sanfey H. Gender-specific issues in liver and kidney failure and transplantation: a review. J Women's Health (Larchmt). 2005;14(7):617–26.CrossRef Sanfey H. Gender-specific issues in liver and kidney failure and transplantation: a review. J Women's Health (Larchmt). 2005;14(7):617–26.CrossRef
26.
go back to reference Fussner LA, Charlton MR, Heimbach JK, et al. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int. 2014;34(8):1259–66.PubMedCrossRef Fussner LA, Charlton MR, Heimbach JK, et al. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int. 2014;34(8):1259–66.PubMedCrossRef
28.
go back to reference Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology. 1999;29:719–27.PubMedCrossRef Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology. 1999;29:719–27.PubMedCrossRef
29.
go back to reference Shimizu I, Mizobuchi Y, Yasuda M, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut. 1999;44:127–36.PubMedPubMedCentralCrossRef Shimizu I, Mizobuchi Y, Yasuda M, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut. 1999;44:127–36.PubMedPubMedCentralCrossRef
30.
go back to reference Codes L, Asselah T, Cazals-Hatem D, et al. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut. 2007;56:390–5.PubMedCrossRef Codes L, Asselah T, Cazals-Hatem D, et al. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut. 2007;56:390–5.PubMedCrossRef
31.
go back to reference Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology. 2004;40:1426–33.PubMedCrossRef Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology. 2004;40:1426–33.PubMedCrossRef
33.
go back to reference Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–8.PubMedPubMedCentralCrossRef Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–8.PubMedPubMedCentralCrossRef
34.
go back to reference Zhang W, Jiang R, Hou J, Sun B. Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer. Medicine (Baltimore). 2015;94(12):e684.CrossRef Zhang W, Jiang R, Hou J, Sun B. Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer. Medicine (Baltimore). 2015;94(12):e684.CrossRef
35.
go back to reference Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.PubMedCrossRef Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.PubMedCrossRef
36.
go back to reference Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol. 2014;28:753–70.PubMedCrossRef Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol. 2014;28:753–70.PubMedCrossRef
37.
go back to reference Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, Holmberg SD. Chronic hepatitis C virus infection in the United States, National Health and nutrition examination survey 2003 to 2010. Ann Intern Med. 2014;160:293–300.PubMedPubMedCentralCrossRef Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, Holmberg SD. Chronic hepatitis C virus infection in the United States, National Health and nutrition examination survey 2003 to 2010. Ann Intern Med. 2014;160:293–300.PubMedPubMedCentralCrossRef
38.
go back to reference Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–32.PubMedCrossRef Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825–32.PubMedCrossRef
39.
go back to reference Deuffic-Burban S, Poynard T, Valleron AJ. Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. J Viral Hepat. 2002;9:114–22.PubMedCrossRef Deuffic-Burban S, Poynard T, Valleron AJ. Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model. J Viral Hepat. 2002;9:114–22.PubMedCrossRef
40.
go back to reference Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, et al. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl. 2009;15(9):1083–91.PubMedCrossRef Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, et al. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl. 2009;15(9):1083–91.PubMedCrossRef
41.
go back to reference Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int. 1998;54:518–24.PubMedCrossRef Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int. 1998;54:518–24.PubMedCrossRef
42.
go back to reference McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55:121–8.PubMedCrossRef McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55:121–8.PubMedCrossRef
43.
go back to reference Lima EQ, Zanetta DM, Castro I, Massarollo PC, Mies S, Machado MM, Yu L. Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003;25:553–60.PubMedCrossRef Lima EQ, Zanetta DM, Castro I, Massarollo PC, Mies S, Machado MM, Yu L. Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003;25:553–60.PubMedCrossRef
44.
go back to reference Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transpl. 1998;12:123–9. Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transpl. 1998;12:123–9.
45.
go back to reference Bajjoka I, Hsaiky L, Brown K, Abouljoud M. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors. Liver Transpl. 2008;14:66–72.PubMedCrossRef Bajjoka I, Hsaiky L, Brown K, Abouljoud M. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors. Liver Transpl. 2008;14:66–72.PubMedCrossRef
46.
go back to reference Soliman T, Hetz H, Burghuber C, Györi G, Silberhumer G, Steininger R, et al. Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation. Transpl Int. 2007;20:447–52.PubMedCrossRef Soliman T, Hetz H, Burghuber C, Györi G, Silberhumer G, Steininger R, et al. Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation. Transpl Int. 2007;20:447–52.PubMedCrossRef
47.
go back to reference Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, et al. Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010;32:776–86.PubMedPubMedCentralCrossRef Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, et al. Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010;32:776–86.PubMedPubMedCentralCrossRef
48.
go back to reference Lin CC, Chuang FR, Lee CH, Wang CC, Chen YS, Liu YW, et al. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation. Liver Transpl. 2005;11:1258–64.PubMedCrossRef Lin CC, Chuang FR, Lee CH, Wang CC, Chen YS, Liu YW, et al. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation. Liver Transpl. 2005;11:1258–64.PubMedCrossRef
50.
go back to reference Colombo D, Chimenti S, Grossi PA, Marchesoni A, Bardazzi F, Ayala F, on behalf of SYNERGY Study Group, et al. Prevalence of acute and chreonic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infectious events in psoriasis complicated by active psoriatic arthritis Clinical. Clin Cosmet Investig Dermatol. 2015;9:1–7.PubMedPubMedCentral Colombo D, Chimenti S, Grossi PA, Marchesoni A, Bardazzi F, Ayala F, on behalf of SYNERGY Study Group, et al. Prevalence of acute and chreonic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infectious events in psoriasis complicated by active psoriatic arthritis Clinical. Clin Cosmet Investig Dermatol. 2015;9:1–7.PubMedPubMedCentral
51.
go back to reference Colombo D, Abbruzzese G, Antonini A, Barone P, Bellia G, Franconi F, et al. The “gender factor” in wearing-off among patients with Parkinson’s disease: a post hoc analysis of DEEP study. ScientificWorldJournal. 2015;2015:787451.PubMedPubMedCentralCrossRef Colombo D, Abbruzzese G, Antonini A, Barone P, Bellia G, Franconi F, et al. The “gender factor” in wearing-off among patients with Parkinson’s disease: a post hoc analysis of DEEP study. ScientificWorldJournal. 2015;2015:787451.PubMedPubMedCentralCrossRef
52.
go back to reference Colombo D, Banfi G, Cassano N, Graziottin A, Vena GA, Fiori GG, on behalf of the “GENDER ATTENTION” study group, et al. The GENDER ATTENTION observational study: gender and hormonal status differences in the incidence of adverse events during cyclosporine treatment in psoriatic patients. Adv Ther. 2017;34(6):1349–63.PubMedPubMedCentralCrossRef Colombo D, Banfi G, Cassano N, Graziottin A, Vena GA, Fiori GG, on behalf of the “GENDER ATTENTION” study group, et al. The GENDER ATTENTION observational study: gender and hormonal status differences in the incidence of adverse events during cyclosporine treatment in psoriatic patients. Adv Ther. 2017;34(6):1349–63.PubMedPubMedCentralCrossRef
Metadata
Title
The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): a post-hoc between-sex analysis
Authors
Delia Colombo
Alessandro Zullo
Lucia Simoni
Emanuela Zagni
on behalf of the SURF Study Group
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1656-8

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue